Why Model Batch and Biology Together?
An omics measurement can vary across samples because of biology, technical processing, or both. For example, a treatment group may have higher abundance for a feature, while samples processed in one laboratory batch also tend to have higher recorded values. A useful first model represents these contributions separately: biological covariates describe systematic differences of scientific interest, and batch indicators represent additive measurement offsets.
The model is feature-wise: fit a separate regression for each measured feature. Its coefficients are conditional associations, not automatic evidence of causal effects. In particular, including batch indicators does not guarantee that the biological effect can be distinguished from batch when the study design provides little or no overlap.
Interpret the Coefficients in Context
For a quantitative biological covariate, its coefficient is the expected change in the measured feature for a one-unit increase in that covariate, holding the other covariates and batch fixed. Its units are the feature’s measurement units per covariate unit. If the feature is log base 2 abundance and the covariate is age in years, the coefficient is in log base 2 units per year.
For a binary biological covariate coded 0 and 1, its coefficient is the expected difference between the group coded 1 and the group coded 0, conditional on the other model terms. A batch coefficient is interpreted similarly as a conditional difference, but it describes a batch-associated measurement offset relative to the chosen reference batch. Changing the reference batch changes the intercept and batch coefficients, but not fitted values or the underlying pairwise batch differences.
The model assumes the biological covariate effect is shared across batches. For instance, a single treatment coefficient says the expected treated-versus-control difference is the same in every batch. If the scientific question or data suggests otherwise, this model may be too restrictive; a treatment-by-batch interaction would represent different treatment coefficients. That is a different model, not a reinterpretation of the additive coefficient.
Worked Example: A Treatment Effect and a Batch Offset
Suppose log base 2 abundance for one hypothetical feature is recorded in two batches, A and B, for control and treated samples. The values are:
| Batch | Control values | Treated values |
|---|---|---|
| A | 8, 10 | 12, 14 |
| B | 11, 13 | 15, 17 |
Use batch A as the reference and code treatment as \(x_i=1\) for treated and 0 for control. The model is \(y_{ig}=\beta_{0g}+\beta_{1g}x_i+\gamma_{Bg}I(b_i=B)+\varepsilon_{ig}\). The four cell means are 9, 13, 12, and 16, respectively. They are exactly represented by the additive model:
The predicted mean for treated samples in batch B is \(9+4+3=16\), matching that cell’s mean. In context, the fitted treatment difference is 4 log base 2 units, conditional on batch, and batch B is 3 log base 2 units higher than batch A at the same treatment status. These are additive associations for this feature; they do not establish that treatment caused the difference.
Estimation and a Short Justification
To fit the model, form a design matrix \(X\) with one column for the intercept, columns for biological covariates, and reference-coded batch-indicator columns. For one feature, collect the observations in vector \(y_g\). When the columns of \(X\) are linearly independent, the ordinary least-squares estimate minimizes the sum of squared residuals and is
where \(\theta_g\) collects the intercept, biological coefficients, and batch coefficients. The formula follows from minimizing \(S(\theta_g)=(y_g-X\theta_g)^\mathsf{T}(y_g-X\theta_g)\). Differentiating with respect to \(\theta_g\) gives \(-2X^\mathsf{T}(y_g-X\theta_g)\); setting this equal to zero yields the normal equations \(X^\mathsf{T}X\hat{\theta}_g=X^\mathsf{T}y_g\). If \(X^\mathsf{T}X\) is invertible, solving those equations gives the stated estimate.
The coefficient estimates describe the fitted conditional mean whether or not the errors are normally distributed. Conventional standard errors and tests require additional assumptions. A common model assumes \(E(\varepsilon_{ig}\mid X)=0\), independent errors across samples, and a common error variance \(\sigma_g^2\). Under these conditions, the usual variance estimate is \(s_g^2=\mathrm{SSE}_g/(n-p)\), where \(\mathrm{SSE}_g\) is the residual sum of squares, \(n\) is the number of samples, and \(p\) is the number of estimated coefficients. Normal errors conditional on \(X\) additionally give exact \(t\)-based inference in finite samples. These assumptions concern the residuals after accounting for the model terms, not whether the raw measurements themselves look normally distributed.
Worked Example: Adjusting an Unbalanced Treatment Comparison
Consider another hypothetical feature measured in batches A and B. In batch A, three control values are 9, 10, and 11, with mean 10, and one treated value is 14. In batch B, one control value is 13, and three treated values are 16, 17, and 18, with mean 17. Both treatment groups occur in both batches. The within-batch means are 10 and 14 in A, and 13 and 17 in B.
The treated-minus-control difference is 4 in each batch. With a common treatment effect and an additive batch offset, the fitted coefficients are therefore
The model predicts a batch B treated mean of \(10+4+3=17\), as observed. By contrast, ignoring batch gives a control mean of \((9+10+11+13)/4=10.75\) and a treated mean of \((14+16+17+18)/4=16.25\). The unadjusted difference is \(16.25-10.75=5.50\), not 4. The difference occurs because the treatment groups contain different proportions of samples from the higher-measurement batch. The adjusted coefficient is the model’s common within-batch treatment contrast, not a guarantee that adjustment is appropriate under every design or mean structure.
Worked Example: A Continuous Biological Covariate
Suppose a hypothetical feature is measured in log base 2 units, and age is recorded in years. In each of two batches, samples at ages 20, 30, and 40 have replicate values that average, respectively, 5, 6, and 7 in batch A, and 8, 9, and 10 in batch B. Fit the additive model using \(a_i=\text{age}_i-20\), so the intercept has a useful interpretation at age 20.
In batch A, the mean increase from age 20 to age 40 is \(7-5=2\) log base 2 units over 20 years. The fitted slope is \(2/20=0.1000\) log base 2 units per year. At age 20, batch B is \(8-5=3\) units above batch A. Thus the fitted mean is
For a batch B sample aged 30, the predicted value is \(5+0.1000(10)+3=9\), matching the batch B mean at that age. The biological coefficient describes the common age association after holding batch fixed; the batch coefficient describes the offset at the same age. These cell means illustrate coefficient interpretation. Replicate-level residuals, rather than these means alone, are needed to estimate residual variation and assess uncertainty.
Assumptions, Diagnostics, and Alternatives
The additive model is useful when a constant batch shift is a reasonable description for the feature and the biological relationships are adequately represented by the chosen covariates. Its main assumptions and practical checks include:
- Correct conditional mean: after accounting for the biological covariates and batch indicators, residuals should not show systematic patterns by batch or by a biological covariate. Residual-versus-fitted plots and residual summaries by batch can reveal remaining structure.
- Additive batch shifts: a batch offset should not change across the range of a biological covariate, and the biological coefficient should not change across batches. Compare within-batch patterns or inspect residual patterns; visibly different slopes or treatment contrasts suggest that a common additive effect may be inadequate.
- Independent observations and suitable variance assumptions: repeated or correlated samples can make ordinary standard errors inappropriate, while changing residual spread across fitted values or batches can undermine a common-variance calculation. The design and residual plots help identify these concerns.
- Adequate covariate form: a straight-line term may be unsuitable for a nonlinear biological relationship. Residual trends can indicate that a transformation or a more flexible covariate representation is needed.
A common alternative is to compare groups without including batch. This is simple but can mix biological differences with unequal batch composition, as the preceding example showed. Estimating a separate biological contrast within each batch avoids imposing one common contrast, but produces several estimates and can be imprecise, especially with few samples. The additive model instead pools information under the assumption of one shared biological effect and constant batch offsets. A model with interaction terms is an alternative when the biological association plausibly varies by batch, but it estimates additional parameters and requires enough informative data.
The model also has limits that diagnostics cannot erase. Batch indicators adjust modeled mean offsets; they do not repair all technical variation, measurement error, nonlinear batch effects, or unmeasured biological differences. If batch and biology are strongly entangled, coefficient estimates may be unstable; if the data cannot separate their contributions, an additive formula alone cannot create that information. The key is to interpret coefficients as conditional comparisons supported by the observed design, not as automatic correction or proof of causation.
Check Your Understanding
Answer each question, then compare your reasoning with the solutions.
- In the reference-coded model, what does \(\gamma_{3g}=2.5\) mean if batch 1 is the reference and feature \(g\) is measured in log base 2 units?
- A binary treatment coefficient is \(-0.8\). State its interpretation when treatment is coded 1, control is coded 0, and batch and other covariates are held fixed.
- Why might an unadjusted treatment mean difference disagree with the treatment coefficient from an additive model when treatment groups have different batch proportions?
- What pattern in residuals could suggest that a single additive batch offset is inadequate?
Solutions. (1) At the same modeled biological covariate values, the expected feature value in batch 3 is 2.5 log base 2 units higher than in reference batch 1. (2) The fitted treated-versus-control difference is 0.8 log base 2 units lower, conditional on the other included terms; this is an association, not by itself a causal effect. (3) The raw difference combines within-batch differences with differences in batch composition, whereas the model’s treatment coefficient is a conditional contrast holding batch fixed. (4) Systematic residual differences by batch, or differing residual-versus-covariate trends across batches, can indicate that the offsets or shared biological effects assumed by the model do not fit well.